NCT03050723View on ClinicalTrials.gov

Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

November 20, 2016

Primary Completion Date

July 17, 2017

Study Completion Date

January 16, 2018

Conditions
Facial LipoatrophyMorphological Asymmetry of the FaceDebilitating Scars
Interventions
DEVICE

Princess® FILLER

Princess® FILLER injections up to 10 ml applied to the eligible subjects at the baseline visit, and the touch-up visit, if applicable.

Trial Locations (3)

Unknown

Medical University Graz, Graz

MÄZ WIEN (Medizinisch Ästhetisches Zentrum Wien), Vienna

Ordination Dr. Benjamin Gehl, Vienna

Sponsors

Lead Sponsor

Croma-Pharma GmbH
All Listed Sponsors
lead

Croma-Pharma GmbH

INDUSTRY

NCT03050723 - Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars | Biotech Hunter | Biotech Hunter